As outlined previously, the simultaneous downregulation of F4/80+ and CD206+ TAMs, in addition to anti-CD24 mAb treatment, led to a noteworthy augmentation in the amount of CD4+ and CD8+ T cells within the tumour microenvironments (TMEs) of oral squamous cell carcinoma (OSCC). This evidence concerns the gene CD24 and neoplasm.